Elucidating the precise pharmacological mechanism of motion (MOA) of naturally occurring compounds is usually challenging. Even though Tarselli et al. (60) made the first de novo artificial pathway to conolidine and showcased that this Obviously happening compound efficiently suppresses responses to both of those chemically induced and inflammation